Case control, family and population studies and/or other FLG mutations, which then followed, more clearly indicate the meaning of a defective epidermal barrier in pathogenesis, primarily AD, and then other atopic disorders – AR and asthma (61, 62). This evidence concerns the gene FLG and Alzheimer disease.